Patterned entry and egress by Epstein-Barr virus in polarized CR2- positive epithelial cells

Virology

Volumn 266, Issue 2, 2000, Pages 387-396

  Chodosh, James ^a   Gan, Yan jun ^a,b   Holder, Virgil P ^a   Sixbey, John W ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; APICAL MEMBRANE; ARTICLE; B LYMPHOCYTE; BASOLATERAL MEMBRANE; CELL AGGREGATION; CELL MEMBRANE; CELL POLARITY; CELL STRAIN; CELL SURFACE; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; HUMAN HERPESVIRUS 4; RNA VIRUSES;

EID: 0034688155     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0082     Document Type: Article

References (55)

1. Ahearn J. M., Hayward S. D., Hickey J. C., Fearon D. T. Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor. Proc. Natl. Acad. Sci. USA. 85:1988;9307-9311.
2. Anagnostopoulos I., Hummel M., Kreschel C., Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual infection route of Epstein-Barr virus. Blood. 85:1995;744-750.
3. Billaud M., Busson P., Huang D., Mueller-Lantzch N., Rousselet G., Pavlish O., Wakasugi H., Seigneurin J. M., Tursz T., Lenoir G. M. Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B cell activation antigen Blast2/CD23 and low levels of the EBV receptor CR2. J. Virol. 63:1987;4121-4128.
4. Birkenback M., Tong X., Bradbury L. E., Kieff E. Characterization of an Epstein-Barr virus receptor on human epithelial cells. J. Exp. Med. 176:1992;1405-1414.
5. Blau D. M., Compans R. W. Polarization of viral entry and release in epithelial cells. Semin. Virol. 7:1996;245-253.
6. Borza C. M., Hutt-Fletcher L. M. Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells. J. Virol. 72:1998;7577-7582.
7. Brooks L., Yao Q. Y., Rickinson A. B., Young L. S. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression in EBNA1, LMP1, and LMP2 transcripts. J. Virol. 66:1992;2689-2697.
8. Calander A., Billaud M., Aubry J.-P., Banchereau J., Vuillaume M., Lenoir G. M. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. Natl. Acad. Sci. USA. 84:1987;8060-8064.
9. Clayson E. T., Compans R. W. Entry of simian virus restricted to apical surfaces of polarized epithelial cells. Mol. Cell. Biol. 8:1988;3391-3396.
10. Diehl V., Henle G., Henle W., Kohn G. Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis. J. Virol. 2:1968;663-669.
11. Doherty P. C., Tripp R. A., Hamilton-Easton A. M., Cardin R. D., Woodland D. L., Blackman M. Tuning into immunological dissonance: An experimental model for infectious mononucleosis. Curr. Opin. Immunol. 9:1997;477-483.
12. Fingeroth J. D., Weiss J. J., Tedder T. F., Strominger J. L., Biro P. A., Fearon D. T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA. 81:1984;4510-4514.
13. Fingeroth J. D., Diamond M. E., Sage D. R., Hayman J., Yates J. L. CD21-dependent infection of an epithelial cell line, 293, by Epstein-Barr virus. J. Virol. 73:1999;2115-2125.
14. Fujisaku A., Harley J. B., Frank M. B., Gruner B. A., Frazier B., Holers V. M. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor. J. Biol. Chem. 264:1989;2118-2125.
15. Fuller S. D., von Bonsdorff C.-H., Simons K. Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK. Cell. 38:1984;65-77.
16. Gan Y.-J., Chodosh J., Morgan A., Sixbey J. W. Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus. J. Virol. 71:1997;519-526.
17. Gong M., Kieff E. Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110. J. Virol. 64:1990;1507-1516.
18. Gradoville L., Grogan E., Taylor N., Miller G. Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by OriP/BZLF1 plasmids. Virology. 178:1990;345-354.
19. Henderson A., Ripley S., Heller M., Kieff E. Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proc. Natl. Acad. Sci. USA. 80:1983;1987-1991.
20. Imai S., Nishikawa J., Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 72:1998;4371-4378.
21. Karajannis M. A., Hummel M., Anagnostopoulos I., Stein H. Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in nonimmunocompromised individuals. Blood. 89:1997;2856-2862.
22. King W., Thomas-Powell A. L., Raab-Traub N., Kieff E. Epstein-Barr virus RNA: Viral RNA in a restringently infected, growth-transformed cell line. J. Virol. 36:1980;506-518.
23. Knox P. G., Li Q.-X., Rickinson A. B., Young L. S. In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus:cell interaction observed in nasopharyngeal carcinoma. Virology. 215:1996;40-50.
24. Lemon S. M., Hutt L. M., Shaw J. E., Li J.-L. H., Pagano J. S. Replication of EBV in epithelial cells during infectious mononucleosis. Nature. 268:1977;268-270.
25. Li Q.-X., Young L. S., Niedobitek G., Dawson C. W., Birkenbach M., Wang F., Rickinson A. B. Epstein-Barr virus infection and replication in a human epithelial cell system. Nature. 356:1992;347-350.
26. Li Q.-X., Spriggs M. K., Kovats S., Turk S. M., Comeau M. R., Nepom B., Hutt-Fletcher L. M. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 71:1997;4657-4662.
27. MacMahon E. M. E., Glass J. D., Hayward S. D., Mann R. B., Becker P. S., Charache P., McArthur J. C., Ambinder R. E. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet. 338:1991;969-973.
28. Miller G., Lipman M. Release of Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA. 70:1973;190-194.
29. Moss D. J., Pope J. H. Assay of the infectivity of Epstein-Barr virus by transformation of human leukocytes in vitro. J. Gen. Virol. 17:1972;233-236.
30. Owens R. J., Compans R. W. Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J. Virol. 63:1989;978-982.
31. Owens R. J., Dubay J. W., Hunter E., Compans R. W. The human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc. Natl. Acad. Sci. USA. 88:1991;3987-3991.
32. Pulvertaft R. J. V. Cytology of Burkitt's tumour (African lymphoma). Lancet. 1:1964;238-240.
33. Raab-Traub N., Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 47:1986;883-889.
34. Rodriguez-Boulan E., Pendergast M. Polarized distribution of viral envelope proteins in the plasma membrane of infected epithelial cells. Cell. 20:1980;45-54.
35. Rossen J. W. A., Bekker C. P., Voorhout W. F., Strous G. J., van der Ende A., Rottier P. J. Entry and release of transmissible gastroenteritis coronovirus are restricted to apical surfaces of polarized epithelial cells. J. Virol. 68:1994;7966-7973.
36. Roth M. G., Compans R. W., Giusti L., Davis A. R., Nayak D. D., Gething M. J., Sambrook J. S. Influenza virus hemagglutinin expression is polarized in cells infected with recombinant SV40 viruses carrying cloned hemagglutinin DNA. Cell. 33:1983;435-443.
37. Sears A. E., McGwire B. S., Roizman B. Infection of polarized MDCK cells with herpes simplex virus 1: Two asymmetrically distributed cell receptors interact with different viral proteins. Proc. Natl. Acad. Sci. USA. 88:1991;5087-5091.
38. Sixbey J. W., Davis D. S., Young L. S., Hutt-Fletcher L., Tedder T. F., Rickinson A. B. Human epithelial cell expression of an Epstein-Barr virus receptor. J. Gen. Virol. 68:1987;805-811.
39. Sixbey J. W., Nedrud J. G., Raab-Traub N., Hanes R. A., Pagano J. S. Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310:1984;1225-1230.
40. Svedmyr E., Ernberg I., Seeley J., Weiland O., Masucci G., Tsukuda K., Szigeti R., Masucci M. G., Blomgren H., Berthold W., Henle W., Klein G. Virologic, immunologic, and clinical observations on a patient during incubation, acute, and convalescent phases of infectious mononucleosis. Clin. Immunol. Immunopathol. 30:1984;437-450.
41. Takada K., Horinouchi K., Ono Y., Ata T., Osato T., Takahashi M., Hayasaka S. An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA. Virus Genes. 5:1991;147-156.
42. Takata K., Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:1989;445-449.
43. Tanner J., Weis J., Fearon D., Whang Y., Kieff E. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell. 50:1987;203-213.
44. Tashiro M., Yamakawa M., Tobito K., Klenk H.-D., Rott R., Seto J. T. Organ tropism of Sendai virus in mice: Proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium. J. Virol. 64:1990a;3627-3634.
45. Tashiro M., Yamakawa M., Tobita K., Seto J. T., Klenk H.-D., Rott R. Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cells. J. Virol. 64:1990b;4672-4677.
46. Tedder T. F., Clement L. T., Cooper M. D. Expression of C3d receptors during human B cell differentiation: Immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immunol. 133:1984;678-683.
47. Thomas J. A., Felix D. H., Wray D., Southam J. C., Cubie H. A., Crawford D. H. Epstein-Barr virus gene expression and epithelial cell differentiation in oral hairy leukoplakia. Am. J. Pathol. 139:1991;1369-1380.
48. Torrisi M. R., Cirone M., Pavan A., Zompetta C., Barile G., Frati L., Faggioni A. Localization of Epstein-Barr virus envelope glycoproteins on the inner nuclear membrane of virus-producing cells. J. Virol. 63:1989;828-832.
49. Tugizov S., Maidji E., Pereira L. Role of apical and basolateral membranes in replication of human cytomegalovirus in polarized retinal pigment epithelial cells. J. Gen. Virol. 77:1996;61-74.
50. van Genderen I. L., van Meer G., Slot J. W., Geuze H. J., Voorhout W. F. Subcellular localization of Forssman glycolipid in epithelial MDCK cells by immuno-electronmicroscopy after freeze-substitution. J. Cell Biol. 115:1991;1009-1019.
51. von Bonsdorff C.-H., Fuller S. D., Simons K. Apical and basolateral endocytosis in Madin-Darby canine kidney (MDCK) cells grown on nitrocellulose filters. EMBO J. 4:1985;2781-2792.
52. Wang X., Kenyon W. J., Li Q., Müllberg J., Hutt-Fletcher L. M. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J. Virol. 72:1998;5552-5558.
53. Webster-Cyriaque J., Raab-Traub N. Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia. Virology. 248:1998;53-65.
54. Yoshiyama H., Imai S., Shimizu N., Takada K. Epstein-Barr virus infection of human gastric carcinoma cells: Implications of the existence of a new virus receptor different from CD21. J. Virol. 71:1997;5688-5691.
55. Young L. S., Lau R., Rowe M. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol. 65:1991;2868-2874.